Evidence map›Paper›PMID 33583468›Full record

ArticleInfection control and hospital epidemiology2021

Institutional policies and readiness in management of critical illness among patients with viral hemorrhagic fever.

Madeline A DiLorenzo, Christoph A Baker, Jocelyn J Herstein, Laura Evans, John J Lowe, Shawn G Gibbs, Nahid Bhadelia

Abstract read
PubMed Publisher
In one paragraph

Article in Infection control and hospital epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Madeline A DiLorenzoDepartment of Internal Medicine, Boston Medical Center, Boston, Massachusetts.ORCID 0000-0003-1284-6428
Christoph A BakerTufts University School of Medicine, Boston, Massachusetts.
Jocelyn J HersteinGlobal Center for Health Security, University of Nebraska Medical Center, Omaha, Nebraska.
Laura EvansDivision of Pulmonary, Critical Care, and Sleep Medicine, University of Washington School of Medicine, Seattle, Washington.
John J LoweGlobal Center for Health Security, University of Nebraska Medical Center, Omaha, Nebraska.
Shawn G GibbsSchool of Public Health, Texas A&M University, College Station, Texas.
Nahid BhadeliaSpecial Pathogens Unit, National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn response to the 2013-2016 Ebola virus disease outbreak, the US government designated certain healthcare institutions as Ebola treatment centers (ETCs) to better prepare for future emerging infectious disease outbreaks. This study investigated ETC experiences and critical care policies for patients with viral hemorrhagic fever (VHF).

designA 58-item questionnaire elicited information on policies for 9 critical care interventions, factors that limited care provision, and innovations developed to deliver care. SETTING AND

participantsThe questionnaire was sent to 82 ETCs.

methodsWe analyzed ordinal and categorical data pertaining to the ETC characteristics and descriptive data about their policies and perceived challenges. Statistical analyses assessed whether ETCs with experience caring for VHF patients were more likely to have critical care policies than those that did not.

resultsOf the 27 ETCs who responded, 17 (63%) were included. Among them, 8 (47%) reported experience caring for persons under investigation or confirmed cases of VHF. Most felt ready to provide intubation, chest compressions, and renal replacement therapy to these patients. The factors most cited for limiting care were staff safety and clinical futility. Innovations developed to better provide care included increased simulation training and alternative technologies for procedures and communication.

conclusionsThere were broad similarities in critical care policies and limitations among institutions. There were several interventions, namely ECMO and cricothyrotomy, which few institutions felt ready to provide. Future studies could identify obstacles to providing these interventions and explore policy changes after increased experience with novel infectious diseases, such as COVID-19.

Indexed as

COVID-19Hemorrhagic Fever, EbolaCritical IllnessDisease OutbreaksHumansOrganizational PolicySARS-CoV-2

Identifiers

PMID33583468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.